Protective effects of the β3-adrenoceptor agonist CL316243 against N-methyl-D-aspartate-induced retinal neurotoxicity

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 11, 2012, Pages 1077-1081

  Oikawa, Fuka ^a   Nakahara, Tsutomu ^a   Akanuma, Kaori ^a   Ueda, Kaori ^a   Mori, Asami ^a   Sakamoto, Kenji ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

3 adrenoceptor; Excitotoxicity; Glutamate; Retina; Retinal blood vessel

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; L 748337; N METHYL DEXTRO ASPARTIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DRUG MECHANISM; EYE PROTECTION; MALE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; RETINA INJURY; RETINA INNER PLEXIFORM LAYER; RETINAL NEUROTOXICITY; VITREOUS BODY;

ADRENERGIC BETA-3 RECEPTOR AGONISTS; AMINOPHENOLS; ANIMALS; DIOXOLES; DISEASE MODELS, ANIMAL; INTRAVITREAL INJECTIONS; MALE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RETINAL DISEASES; RETINAL GANGLION CELLS; SULFONAMIDES; TIME FACTORS;

EID: 84867867720     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0796-1     Document Type: Article

References (28)

1. Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB (2010) Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes. Am J Pathol 177:1187-1197
2. Ambati J, Chalam KV, Chawla DK, D'Angio CT, Guillet EG, Rose SJ, Vanderlinde RE, Ambati BK (1997) Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 115:1161-1166
3. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783-791
4. De La Cruz JP, Gonzalez-Correa JA, Guerrero A, de la Cuesta FS (2004) Pharmacological approach to diabetic retinopathy. Diabetes Metab Res Rev 20:91-113
5. Dkhissi O, Chanut E, Wasowicz M, Savoldelli M, Nguyen-Legros J, Minvielle F, Versaux-Botteri C (1999) Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci 40:990-995
6. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA (1996) Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114:299-305
7. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefansson E (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21:359-393
8. Grieshaber MC, Flammer J (2005) Blood flow in glaucoma. Curr Opin Ophthalmol 16:79-83
9. Hallett PJ, Standaert DG (2004) Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol Ther 102:155-174
10. 1 receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats. Diabetologia 47:113-123
11. Hynd MR, Scott HL, Dodd PR (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45:583-595
12. Izumi Y, Hammerman SB, Kirby CO, Benz AM, Olney JW, Zorumski CF (2003) Involvement of glutamate in ischemic neurodegeneration in isolated retina. Vis Neurosci 20:97-107
13. Kim SA, Jeon JH, Son MJ, Cha J, Chun MH, Kim IB (2010) Changes in transcript and protein levels of calbindin D28k, calretinin and parvalbumin, and numbers of neuronal populations expressing these proteins in an ischemia model of rat retina. Anat Cell Biol 43:218-229
14. Lam TT, Abler AS, Kwong JM, Tso MO (1999) N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci 40:2391-2397
15. Mori A, Saigo O, Hanada M, Nakahara T, Ishii K (2009a) Hyperglycemia accelerates impairment of vasodilator responses to acetylcholine of retinal blood vessels in rats. J Pharmacol Sci 110:160-168
16. Mori A, Ishii T, Kuroki T, Shigeta N, Sakamoto K, Nakahara T, Ishii K (2009b) The prostanoid EP2 receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina. Eur J Pharmacol 616:64-67
17. 3-adrenoceptors in rat retinal blood vessels. Naunyn- Schmiedeberg's Arch Pharmacol 382:119-126
18. Nakazawa T, Kaneko Y, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K (2007) Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats. Vascular Pharmacol 46:153-159
19. Nakazawa T, Sato A, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K (2008) β-Adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats. Vascular Pharmacol 49:77-83
20. Ng YK, Zeng XX, Ling EA (2004) Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats. Brain Res 1018:66-72
21. Nucci C, Tartaglione R, Rombolà L, Morrone LA, Fazzi E, Bagetta G (2005) Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 26:935-941
22. Pulido JE, Pulido JS, Erie JC, Arroyo J, Bertram K, Lu MJ, Shippy SA (2007) A role for excitatory amino acids in diabetic eye disease. Exp Diabetes Res 2007:36150
23. Schmetterer L, Wolzt M (1999) Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 42:387-405
24. Siliprandi R, Canella R, Carmignoto G, Schiavo N, Zanellato A, Zanoni R, Vantini G (1992) N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci 8:567-573
25. Ueda K, Nakahara T, Hoshino M, Mori A, Sakamoto K, Ishii K (2010) Retinal blood vessels are damaged in a rat model of NMDA-induced retinal degeneration. Neurosci Lett 485:55-59
26. 3- adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 374:385-398
27. Wässle H, Grünert U, Röhrenbeck J (1993) Immunocytochemical staining of AII-amacrine cells in the rat retina with antibodies against parvalbumin. J Comp Neurol 332:407-420
28. Zheng L, Gong B, Hatala DA, Kern TS (2007) Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci 48:361-367